stockrow
Friday 6 November 2026
Export XWEL’s income statement to Excel — free account
XWELL, Inc.
XWEL Healthcare Diagnostics & Research
XWELL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.2 million, down 13.8% from fiscal 2024.
- Revenue
- −7.08%
- EPS
- +53.6%
- Free cash flow
- −43.0%
Quarter to June 2026, against a year earlier
0.57
0.03
−5.00%
Follow XWEL
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 3 | 3 | 7 | 3 | 4 | 4 | 3 | 1 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 67.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(63.81) | (26.42) | (17.21) | (7.65) | 1.80 | (4.30) | (15.60) | (15.51) | (4.34) | (2.99) |
P/S ratio |
0.09 | 0.21 | 0.23 | 0.65 | 2.86 | 6.33 | 0.07 | 0.09 | 0.66 | 2.76 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 30.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(156.35) | (63.17) | (38.85) | (17.16) | (1.47) | (6.53) | (41.58) | (39.76) | (11.15) | (5.03) |
P/Operating CF |
(60.90) | (2.01) | (2.15) | (5.39) | 24.52 | (6.56) | 4.94 | (2.34) | (26.68) | (6.05) |
Beneish M-Score |
(6.38) | (3.69) | (4.11) | 2.66 | — | — | — | — | — | — |
P/B ratio |
0.00 | 0.90 | 0.33 | 0.76 | 2.11 | 0.66 | 0.00 | 0.35 | 0.71 | 0.52 |
Dividend Safety Score |
0 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.00 | 1.31 | 0.38 | 0.92 | 2.19 | 0.67 | 0.00 | 1.15 | 2.21 | 1.10 |
EV/Sales |
0.18 | (0.02) | (0.40) | (0.03) | 1.53 | (3.38) | 0.22 | 0.29 | 0.67 | 1.81 |
EV/EBITDA |
0.00 | 0.06 | 0.68 | 0.06 | 12.54 | 0.86 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.59) | 0.07 | 0.76 | 0.06 | 7.77 | 1.13 | (93.41) | (2.21) | (2.67) | (2.57) |
EV/FCF |
(0.44) | 0.06 | 0.66 | 0.05 | 16.23 | 0.96 | (4.39) | (1.54) | (1.94) | (2.55) |
Quick Ratio |
0.32 | 1.47 | 2.65 | 4.11 | 5.35 | 6.66 | 0.13 | 0.20 | 0.57 | 1.52 |
Current Ratio |
0.46 | 1.66 | 2.85 | 4.32 | 5.50 | 6.81 | 0.24 | 0.35 | 1.29 | 2.59 |
Net Debt/EBITDA |
(0.08) | 0.82 | 1.29 | 1.67 | (10.99) | 2.48 | (0.98) | (0.46) | (0.02) | 4.42 |
Debt/Assets |
32.00% | 0.00% | 0.00% | 3.67% | 4.97% | 8.19% | 32.83% | 21.25% | 9.96% | 7.85% |
Debt/Equity |
(0.28) | 0.00 | 0.00 | 0.05 | 0.06 | 0.11 | (3.72) | 0.49 | 0.14 | 0.10 |
Asset Turnover |
1.60 | 1.05 | 0.55 | 0.57 | 0.64 | 0.13 | 1.64 | 1.05 | 0.66 | 0.18 |
Operating CF/Net income |
0.31 | 0.65 | 0.58 | 0.74 | 4.35 | 0.28 | 0.01 | 0.18 | 0.42 | 0.35 |
Capex/Depreciation |
(0.78) | (0.79) | (0.23) | (0.93) | (1.54) | (0.59) | (0.27) | (0.10) | (0.57) | 0.00 |
Interest Coverage |
— | — | — | (81.15) | 95.51 | (21.89) | (5.47) | (19.01) | (20.13) | (10.43) |
| 1,115.49% | (117.39%) | (80.50%) | (44.41%) | 3.71% | (232.54%) | (401.38%) | (126.21%) | (52.44%) | (45.87%) | |
| (154.41%) | (52.38%) | (50.71%) | (33.22%) | 2.91% | (137.25%) | (71.57%) | (77.65%) | (38.96%) | (36.03%) | |
ROIC |
0.00% | 0.00% | 0.00% | (233.42%) | 342.71% | 0.00% | (210.57%) | (133.71%) | (20.01%) | (20.98%) |
Return on Tangible Assets |
530.99% | (212.74%) | (140.89%) | (82.01%) | 3.50% | (109.73%) | 502.56% | (4,152.34%) | (148.71%) | (68.60%) |
Average Days of Receivables |
19.49 | 19.31 | 20.21 | 18.65 | 3.04 | 0.00 | 0.00 | 0.00 | 5.98 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
54.78% | 59.24% | 69.45% | 55.72% | 32.82% | 190.10% | 29.51% | 32.42% | 33.95% | 80.94% |
Intangible Assets out of Total Assets |
0.01 | 0.10 | 0.07 | 0.11 | 0.03 | 0.01 | 0.24 | 0.30 | 0.48 | 0.41 |
Share Based Compensation of Revenue |
3.70% | 2.63% | 7.71% | 6.92% | 4.39% | 17.45% | 0.69% | 2.32% | 4.51% | 20.97% |
Graham Net Nets |
(7.08) | (0.33) | 1.24 | 0.68 | 0.39 | 1.30 | (8.26) | (2.58) | (0.10) | 0.36 |
Graham Number |
16.27 | 0.00 | 0.00 | 0.00 | 16.08 | 0.00 | 429.83 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1,110.87%) | (239.74%) | (408.25%) | (89.74%) | 1.49% | (176.29%) | (650.78%) | (794.46%) | (89.08%) | (72.15%) |
Free Cash Flow Yield |
(456.56%) | (183.80%) | (267.78%) | (84.94%) | 3.31% | (55.36%) | (72.76%) | (208.20%) | (51.71%) | (25.69%) |
Revenue per Share |
5.25 | 7.35 | 7.21 | 11.95 | 14.14 | 3.76 | 593.82 | 2,070.00 | 2,624.89 | 951.27 |
Operating CF per Share |
(1.57) | (2.39) | (3.85) | (5.17) | 2.79 | (11.22) | (1.38) | (271.32) | (654.41) | (669.92) |
Capex per Share |
(0.53) | (0.39) | (0.57) | (1.46) | (1.46) | (1.95) | (27.85) | (118.43) | (245.27) | (5.24) |
Free Cash Flow per Share |
(2.10) | (2.78) | (4.42) | (6.62) | 1.34 | (13.18) | (29.23) | (389.75) | (899.68) | (675.16) |
Cash per Share |
0.47 | 2.56 | 5.52 | 9.01 | 20.23 | 40.30 | 26.73 | 140.62 | 342.37 | 1,421.43 |
Shareholders Equity per Share |
(2.30) | 1.68 | 5.02 | 10.24 | 19.16 | 36.07 | (31.04) | 542.77 | 2,464.46 | 5,092.78 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(2.30) | 1.68 | 5.02 | 10.24 | 19.16 | 36.07 | (31.04) | 542.77 | 2,464.46 | 5,092.78 |
Free Cash Flow |
(11.68) | (12.80) | (18.45) | (31.02) | 6.97 | (29.36) | (2.39) | (9.43) | (16.73) | (8.51) |
Working Capital |
(6.98) | 6.11 | 17.24 | 36.38 | 89.15 | 78.30 | (12.29) | (10.90) | 3.60 | 18.73 |
Capital Expenditures |
(2.96) | (1.79) | (2.37) | (6.84) | (7.59) | (4.35) | (2.27) | (2.87) | (4.56) | (0.07) |
Net Current Asset Value |
(18.11) | (2.27) | 8.54 | 24.86 | 81.65 | 69.02 | (27.33) | (11.69) | (3.31) | 11.86 |
EV/EBIT |
0.00 | 0.05 | 0.43 | 0.05 | 27.55 | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.10 | 0.05 | 0.08 | 0.12 | 0.10 | 0.52 | 0.05 | 0.06 | 0.09 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 51.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
2.27 | 1.26 | 4.21 | 2.01 | 0.74 | 1.77 | 1.05 | 2.38 | 0.50 | 0.93 |
Cash ROIC |
177.19% | (65.49%) | (41.90%) | (33.46%) | 3.29% | (16.44%) | (26.30%) | (40.94%) | (28.50%) | (9.60%) |
Accounts Receivable Turnover |
17.42 | 19.59 | 13.31 | 32.21 | 104.21 | 0.00 | 0.00 | 0.00 | 93.35 | 0.00 |
Accounts Payable Turnover |
9.76 | 18.43 | 15.50 | 11.19 | 6.90 | 1.26 | 3.65 | 4.67 | 3.95 | 0.80 |
Inventory Turnover |
42.98 | 35.66 | 25.65 | 30.02 | 34.20 | 18.38 | 52.98 | 40.65 | 21.27 | 4.67 |
Average Days of Payables |
47.69 | 23.56 | 15.18 | 19.23 | 48.82 | 197.01 | 121.02 | 75.61 | 81.79 | 595.33 |
Days of Inventory on Hand |
8.56 | 7.32 | 12.43 | 9.65 | 15.55 | 20.01 | 6.24 | 7.24 | 10.85 | 135.75 |
Average Receivables |
1.68 | 1.73 | 2.26 | 1.74 | 0.71 | — | — | — | 0.52 | — |
Average Payables |
2.22 | 1.36 | 1.71 | 3.92 | 6.00 | 9.51 | 10.36 | 8.45 | 9.86 | 8.42 |
Average Inventory |
0.51 | 0.70 | 1.03 | 1.46 | 1.21 | 0.65 | 0.71 | 0.97 | 1.83 | 1.44 |
Average Assets |
18.28 | 32.17 | 54.71 | 98.85 | 115.20 | 65.93 | 29.65 | 47.91 | 74.02 | 66.63 |
Average Common Equity |
(2.53) | 14.36 | 34.46 | 73.94 | 90.15 | 38.91 | 5.29 | 29.48 | 55.00 | 52.34 |
Columns are period end dates · fundamentals updated 25 Oct 2026